Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05751538

Artificial Intelligence in Computed Tomography for Quantifying Lung Changes of Bronchiectasis Patients

Conditions: Bronchiectasis

Sex: All
Enrollment: 730
Sponsor: Ruijin Hospital

Location: China

Summary

Bronchiectasis is a chronic respiratory disease characterized by permanent bronchiectasis.The incidence and prevalence of bronchiectasis have assumed continuously grows in global. Chest computed tomography (CT) remains the imaging standard for demonstrating cystic fibrosis (CF) airway structural disease in vivo. However, visual scoring systems as an outcome measure are time consuming, require training and lack high reproducibility. Our objective was to validate a fully automated artificial intelligence (AI)-driven scoring system of CF lung disease severity.

Eligibility Criteria

Inclusion Criteria:Patients diagnosed with bronchiectasis (according to the Chinese consensus, patient's previous chest CT examination must show bronchiectasis)Exclusion Criteria:Patients with CT data and medical records missing

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05751538). StuddyBuddy aggregates publicly available trial information.